Call for Abstract

15th World Congress on Cancer Therapy, will be organized around the theme “New and Emerging Target Therapies in Oncology”

American Cancer Congress-2016 is comprised of 27 tracks and 71 sessions designed to offer comprehensive sessions that address current issues in American Cancer Congress-2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Clinical Toxicology
  • Track 1-2Pharmacokinetics
  • Track 1-3Pharmacodynamics
  • Track 1-4Drug interactions
  • Track 8-1Radiation Therapy
  • Track 15-1Biomarkers in cancer detection
  • Track 15-2Targeting Protein involving DNA
  • Track 15-3Cancer Epidemiology
  • Track 15-4Stem cell research
  • Track 16-1Drugs and mechanism
  • Track 16-2Therapeutic antibodies & cancer vaccines
  • Track 16-3Novel drug delivery system & cancer drug designing
  • Track 16-4Anticancer drugs in global market: economy & their cost effectiveness
  • Track 16-5Nanotechnology in cancer drugs
  • Track 16-6Functional genomics in drug discovery & development
  • Track 17-1Revisiting tumor metabolism
  • Track 17-2Telomerase: A target for cancer therapeutics
  • Track 17-3Clinical and potential applications of metabolomics in oncology
  • Track 17-4Molecular cancer therapeutics
  • Track 17-5Metabolomics in novel biomarker discovery
  • Track 18-1Treatment strategies
  • Track 18-2Adverse effects
  • Track 18-3Limitations
  • Track 18-4Novel and experimental approaches
  • Track 19-1Nutrition and Supplements
  • Track 19-2Diet and exercise
  • Track 19-3Cancer and Environment
  • Track 19-4
  • Track 20-1Biomarkers in Cancer Research
  • Track 20-2Biomarkers in Medicine
  • Track 20-3Biomarkers in Cancer Medicine
  • Track 20-4Risk assessment, Diagnosis
  • Track 20-5Prognosis and treatment predictions
  • Track 20-6Pharmacodynamics and pharmacokinetics
  • Track 20-7Molecular cancer biomarkers
  • Track 21-1Tumor immunology and immune therapy
  • Track 21-2Molecular and Cellular Oncology
  • Track 21-3Cancer stem cells
  • Track 21-4Cancer Genomics and Systems Biology
  • Track 21-5Cancer Genomics and Systems Biology
  • Track 22-1Radiotherapy and chemotherapy
  • Track 22-2Molecular-targeted therapies
  • Track 22-3Cancer: Gene expression and protein profiling; Surgery and laparoscopy
  • Track 22-4Hormone replacement therapy
  • Track 23-1Brain, Bladder, Breast, Blood, Bone, Oral, Throat Cancer
  • Track 23-2Cervical, Colorectal, Kidney, Liver, Thyroid, Esophageal Cancer
  • Track 23-3Lung, Ovarian, Pancreatic, Prostate, Uterine (Endometrial) Cancer
  • Track 23-4Multiple Myeloma, Skin Cancer, Leukemia
  • Track 24-1CAR T-Cell Therapy
  • Track 24-2Oncolytic viral therapies
  • Track 24-3Gene-therapy
  • Track 24-4Adoptive T-Cell transfer
  • Track 25-1Alternative Medical Systems
  • Track 25-2Mind-Body Methods
  • Track 25-3Nutritional Methods
  • Track 25-4Pharmacologic and Biologic Treatments
  • Track 26-1Cancer Microenvironment
  • Track 26-2Chemo Drugs
  • Track 26-3Stealth Nanoparticles and Tumor Penetrating Peptides
  • Track 26-4Vector/Host Interaction
  • Track 26-5New Nanomaterials
  • Track 26-6Imaging and Theranostics
  • Track 26-7Early Diagnosis and Imaging
  • Track 26-8Advances in Nanotechnology
  • Track 27-1Cancer in Japan
  • Track 27-2Cancer in Sweden
  • Track 27-3Cancer in China
  • Track 27-4Cancer in Malaysia
  • Track 27-5Cancer in Singapore
  • Track 27-6Cancer in America
  • Track 27-7Cancer in Canada